Harmony Biosciences Names Peter Anastasiou CEO
(RTTNews) - Harmony Biosciences Holdings, Inc. (HRMY), a biopharmaceutical company, on Monday announced that Senior Executive Vice President and Chief Operating Officer Peter Anastasiou will become President and CEO and join the Board, effective January 1, 2027.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.